Namita Thappar is the Executive Director of Emcure Pharmaceuticals, one of India’s leading pharmaceutical companies. She is also a regular investor on Shark Tank India, the country’s version of the popular US TV show.

A graduate of the Indian Institute of Management, Ahmedabad, Namita has over 25 years of experience in the pharmaceutical industry. She has held various senior positions in leading Indian and multinational companies, including Pfizer, Ranbaxy, and GlaxoSmithKline.

Namita is a passionate advocate of quality healthcare for all and has been instrumental in Emcure’s journey to becoming a leading player in the Indian pharmaceutical market. Under her leadership, Emcure has launched several innovative products and services that have made a positive impact on the lives of patients.

Some of Emcure’s most notable achievements under Namita’s leadership include the launch of India’s first biosimilar insulin product and the launch of a new anti-cancer drug that is helping patients access affordable treatment.

Namita Thappar is also a strong believer in the power of social media and has used it effectively to connect with Emcure’s patients and create a community of supporters. She is an active user of Twitter and has used it to raise awareness about Emcure’s work and to engage with patients and doctors.

The Emcure team is proud of Namita’s achievements and is confident that under her leadership, the company will continue to make a difference in the lives of patients.